About FDA

Office of Manufacturing Quality

Office Director: Thomas Cosgrove

Office Deputy Director for Science and Regulatory Policy: Rick Friedman

Office Deputy Director for Management and Operations: Kennerly Chapman

Drugs, prescription and over-the-counter (OTC), must be manufactured in accordance with good manufacturing practice requirements. Conformance with these requirements is determined through inspection and compliance evaluations. After approval, routine FDA inspections evaluate the state of control of the process and facility, under the agency’s quality systems inspection program.

Page Last Updated: 07/29/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.